Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Notes Payables (2021 - 2022)

BioScience Health Innovations (BHIC) has disclosed Notes Payables for 2 consecutive years, with $7050.0 as the latest value for Q2 2022.

  • Quarterly Notes Payables changed N/A to $7050.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $7050.0 through May 2022, changed N/A year-over-year, with the annual reading at $7050.0 for FY2021, N/A changed from the prior year.
  • Notes Payables for Q2 2022 was $7050.0 at BioScience Health Innovations, roughly flat from $7050.0 in the prior quarter.
  • The five-year high for Notes Payables was $7050.0 in Q3 2021, with the low at $7050.0 in Q3 2021.